ADRX · Company research
ADARx Pharmaceuticals, Inc. (ADRX): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
12records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| ADRX Price History for Adarx Pharmaceuticals Stock - Barchart.com | ADRX Price History for Adarx Pharmaceuticals Stock Barchart.com | View source ↗ | Barchart.com | Oct 13, 2026 | neutral | 0 | 0.6 |
| Pretax income of ADARx Pharmaceuticals, Inc. – NASDAQ:ADRX - TradingView | Pretax income of ADARx Pharmaceuticals, Inc. – NASDAQ:ADRX TradingView | View source ↗ | TradingView | Oct 12, 2026 | neutral | 0 | 0.6 |
| ADARx Pharmaceuticals, Inc. (ADRX) Stock Price: Oct 7 Close $17.33 - Gotrade | ADARx Pharmaceuticals, Inc. (ADRX) Stock Price: Oct 7 Close $17.33 Gotrade | View source ↗ | Gotrade | Oct 8, 2026 | neutral | 0 | 0.6 |
| Funds buy $17 IPO shares and report holdings in ADARx Pharmaceuticals (ADRX). - Stock Titan | Funds buy $17 IPO shares and report holdings in ADARx Pharmaceuticals (ADRX). Stock Titan | View source ↗ | Stock Titan | Oct 5, 2026 | neutral | 0 | 0.6 |
| At $17 a share, OrbiMed Israel Partners II buys 61,516 IPO shares in ADARx Pharmaceuticals (ADRX). - Stock Titan | At $17 a share, OrbiMed Israel Partners II buys 61,516 IPO shares in ADARx Pharmaceuticals (ADRX). Stock Titan | View source ↗ | Stock Titan | Sep 30, 2026 | neutral | 0 | 0.6 |
| Stock options exercisable at 24 cents sit alongside a trust in ADARx Pharmaceuticals (ADRX) CEO Li Zhen's holdings. - Stock Titan | Stock options exercisable at 24 cents sit alongside a trust in ADARx Pharmaceuticals (ADRX) CEO Li Zhen's holdings. Stock Titan | View source ↗ | Stock Titan | Sep 26, 2026 | neutral | 0 | 0.6 |
| EBITDA margin % of ADARx Pharmaceuticals, Inc. – NASDAQ:ADRX - TradingView | EBITDA margin % of ADARx Pharmaceuticals, Inc. – NASDAQ:ADRX TradingView | View source ↗ | TradingView | Sep 24, 2026 | neutral | 0 | 0.6 |
| ADARx Pharmaceuticals, Inc. Financial Statements – NASDAQ:ADRX - TradingView | ADARx Pharmaceuticals, Inc. Financial Statements – NASDAQ:ADRX TradingView | View source ↗ | TradingView | Sep 24, 2026 | neutral | 0 | 0.6 |
| ADARx Pharmaceuticals, Inc. Statistics – NASDAQ:ADRX - TradingView | ADARx Pharmaceuticals, Inc. Statistics – NASDAQ:ADRX TradingView | View source ↗ | TradingView | Sep 24, 2026 | neutral | 0 | 0.6 |
| Free float of ADARx Pharmaceuticals, Inc. – NASDAQ:ADRX - TradingView | Free float of ADARx Pharmaceuticals, Inc. – NASDAQ:ADRX TradingView | View source ↗ | TradingView | Sep 24, 2026 | neutral | 0 | 0.6 |
| ADARx Pharmaceuticals, Inc. Income Statement – NASDAQ:ADRX - TradingView | ADARx Pharmaceuticals, Inc. Income Statement – NASDAQ:ADRX TradingView | View source ↗ | TradingView | Sep 24, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Sep 22, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.